![](/img/cover-not-exists.png)
5055 High efficacy of the combination of oral vinorelbine (NVBo), capecitabine (X) and trastuzumab (H) in HER2-positive metastatic breast cancer (MBC): updated results of an international phase II trial with a median follow-up of 39 months
A. Chan, V. Ganju, D. Becquart, P.F. Conte, L. Petruzelka, M. Gil-Gil, M. Morand, N. Vaissiere, G. Villanova, N. Tubiana-MathieuVolume:
7
Year:
2009
Language:
english
DOI:
10.1016/s1359-6349(09)70947-4
File:
PDF, 50 KB
english, 2009